Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Isotechnika Pharma Inc IPHAF

GREY:IPHAF - Post Discussion

Isotechnika Pharma Inc > Abnormal volume---price flux.........
View:
Post by ISAloser247 on Jan 11, 2013 3:56pm

Abnormal volume---price flux.........

....must be those elementary schoolkids , playing the stockmarket , with Macquarie , instinet acting as brokers!  Reminds me of those , long ago days , 10 years or so ago , when ISA was c*nning in the 3-4 DOLLAR range , the private jet was jet-setting , everyone thought Al and Dr.Bid / Ask were geniuses, the world was their oyster!

NOW,  just a bunch of old , pathetic , douc**-bag , h*stlers . barely hanging on , as the BIO -TECH world has left them behind !   Everyone gets old , , BUT IN THEIR C*CKINESS AND ARROGANCE, TOO MANY PEOPLE WERE SC*MMED , TOO MUCH WAS LOST BY MANY  IN THEIR C*N , HOPE THEY ROT WITH DEMENTIA , INCONTINENCE ,----- A LEGACY FULFILLED!!!!!

Be the first to comment on this post
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities